Literature DB >> 26423753

Measles in the Democratic Republic of Congo: an urgent wake-up call to adapt vaccination implementation strategies.

S P Gerard1, E Kyrousis2, R Zachariah3.   

Abstract

All countries in Africa have made a commitment to eliminate measles by 2020. This is laudable, as measles elimination will have a crucial impact on reducing childhood mortality. An important operational challenge is the resurgence of measles outbreaks in a number of countries; one of the main reasons for this is that many children are being missed by vaccination programmes. In the Democratic Republic of Congo (DRC), outbreaks continue unabated despite repeated vaccination campaigns and high reported coverage by the Ministry of Health. This paper brings into question the effectiveness of the current approach and the need for better reflection on bottlenecks and strategies that can address this issue. If we are to eliminate measles by 2020, there will be a need for impetus, a need for decisive action to reach that goal and prevent unnecessary childhood deaths in countries such as the DRC.

Entities:  

Keywords:  DRC; elimination; measles; outbreaks; vaccination

Year:  2014        PMID: 26423753      PMCID: PMC4479095          DOI: 10.5588/pha.13.0099

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  2 in total

1.  Back to basics: the miracle and tragedy of measles vaccine.

Authors:  Zsuzsanna Jakab; David M Salisbury
Journal:  Lancet       Date:  2013-04-27       Impact factor: 79.321

2.  Measles in Democratic Republic of Congo: an outbreak description from Katanga, 2010-2011.

Authors:  Lise Grout; Andrea Minetti; Northan Hurtado; Gwenola François; Florence Fermon; Anne Chatelain; Géza Harczi; Jean de Dieu Ilunga Ngoie; Alexandra N'Goran; Francisco J Luquero; Rebecca F Grais; Klaudia Porten
Journal:  BMC Infect Dis       Date:  2013-05-22       Impact factor: 3.090

  2 in total
  6 in total

1.  Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.

Authors:  Heather Melissa Scobie; Benoît Kebela Ilunga; Audry Mulumba; Calixte Shidi; Tiekoura Coulibaly; Ricardo Obama; Jean-Jacques Muyembe Tamfum; Elisabeth Pukuta Simbu; Sheilagh Brigitte Smit; Balcha Masresha; Robert Tyrrell Perry; Mary Margaret Alleman; Katrina Kretsinger; James Goodson
Journal:  Pan Afr Med J       Date:  2015-05-15

2.  Measles vaccination coverage survey in moba, katanga, democratic republic of congo, 2013: need to adapt routine and mass vaccination campaigns to reach the unreached.

Authors:  Julita Gil Cuesta; Narcisse Mukembe; Palle Valentiner-Branth; Pawel Stefanoff; Annick Lenglet
Journal:  PLoS Curr       Date:  2015-02-02

3.  Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?

Authors:  J M Prada; C J E Metcalf; S Takahashi; J Lessler; A J Tatem; M Ferrari
Journal:  Vaccine       Date:  2017-02-16       Impact factor: 3.641

4.  Measles antibody levels among vaccinated and unvaccinated children 6-59 months of age in the Democratic Republic of the Congo, 2013-2014.

Authors:  Hayley R Ashbaugh; James D Cherry; Nicole A Hoff; Reena H Doshi; Vivian H Alfonso; Adva Gadoth; Patrick Mukadi; Stephen G Higgins; Roger Budd; Christina Randall; Guillaume Ngoie Mwamba; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tamfum; Sue K Gerber; Anne W Rimoin
Journal:  Vaccine       Date:  2020-02-24       Impact factor: 3.641

5.  Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo.

Authors:  Hayley R Ashbaugh; Nicole A Hoff; Reena H Doshi; Vivian H Alfonso; Adva Gadoth; Patrick Mukadi; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tamfum; Sue K Gerber; James D Cherry; Anne W Rimoin
Journal:  Vaccine       Date:  2017-12-14       Impact factor: 3.641

6.  Sub-national variation in measles vaccine coverage and outbreak risk: a case study from a 2010 outbreak in Malawi.

Authors:  Avery Kundrick; Zhuojie Huang; Spencer Carran; Matthew Kagoli; Rebecca Freeman Grais; Northan Hurtado; Matthew Ferrari
Journal:  BMC Public Health       Date:  2018-06-15       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.